636 related articles for article (PubMed ID: 29760445)
1. Elevated prenatal anti-Müllerian hormone reprograms the fetus and induces polycystic ovary syndrome in adulthood.
Tata B; Mimouni NEH; Barbotin AL; Malone SA; Loyens A; Pigny P; Dewailly D; Catteau-Jonard S; Sundström-Poromaa I; Piltonen TT; Dal Bello F; Medana C; Prevot V; Clasadonte J; Giacobini P
Nat Med; 2018 Jun; 24(6):834-846. PubMed ID: 29760445
[TBL] [Abstract][Full Text] [Related]
2. Pregnancy and neonatal complications in women with polycystic ovary syndrome in relation to second-trimester anti-Müllerian hormone levels.
Valdimarsdottir R; Valgeirsdottir H; Wikström AK; Kallak TK; Elenis E; Axelsson O; Ubhayasekhera K; Bergquist J; Piltonen TT; Pigny P; Giacobini P; Poromaa IS
Reprod Biomed Online; 2019 Jul; 39(1):141-148. PubMed ID: 31036431
[TBL] [Abstract][Full Text] [Related]
3. [Serum levels of anti-muller hormone in women with polycystic ovary syndrome and healthy women of reproductive age].
Parahuleva N; Pehlivanov B; Orbecova M; Deneva T; Uchikova E
Akush Ginekol (Sofiia); 2013; 52 Suppl 1():16-23. PubMed ID: 24294740
[TBL] [Abstract][Full Text] [Related]
4. [Anti-Mullerian hormone in the major phenotypes of polycystic ovary syndrome].
Parahuleva N; Pehlivanov B; Orbecova M; Uchikova E; Ivancheva H
Akush Ginekol (Sofiia); 2014; 53(5):22-7. PubMed ID: 25558667
[TBL] [Abstract][Full Text] [Related]
5. Serum Anti-Müllerian hormone (AMH) in mothers with polycystic ovary syndrome (PCOS) and their term fetuses.
Detti L; Christiansen ME; Francillon L; Ikuwezunma G; Diamond MP; Mari G; Tobiasz AM
Syst Biol Reprod Med; 2019 Apr; 65(2):147-154. PubMed ID: 30428262
[TBL] [Abstract][Full Text] [Related]
6. Trends in anti-Müllerian hormone concentrations across different stages of pregnancy in women with polycystic ovary syndrome.
Köninger A; Kampmeier A; Schmidt B; Frank M; Strowitzki T; Kimmig R; Gellhaus A; Mach P
Reprod Biomed Online; 2018 Sep; 37(3):367-374. PubMed ID: 30146442
[TBL] [Abstract][Full Text] [Related]
7. Circulating antimüllerian hormone and steroid hormone levels remain high in pregnant women with polycystic ovary syndrome at term.
Piltonen TT; Giacobini P; Edvinsson Å; Hustad S; Lager S; Morin-Papunen L; Tapanainen JS; Sundström-Poromaa I; Arffman RK
Fertil Steril; 2019 Mar; 111(3):588-596.e1. PubMed ID: 30630591
[TBL] [Abstract][Full Text] [Related]
8. Serum anti-Müllerian hormone concentration in women with polycystic ovary syndrome and type 1 diabetes mellitus.
Łebkowska A; Adamska A; Karczewska-Kupczewska M; Nikołajuk A; Otziomek E; Milewski R; Górska M; Wołczyński S; Kowalska I
Metabolism; 2016 May; 65(5):804-811. PubMed ID: 26961579
[TBL] [Abstract][Full Text] [Related]
9. Anti-Müllerian hormone gene polymorphism is associated with androgen levels in Chinese polycystic ovary syndrome patients with insulin resistance.
Zheng MX; Li Y; Hu R; Wang FM; Zhang XM; Guan B
J Assist Reprod Genet; 2016 Feb; 33(2):199-205. PubMed ID: 26732661
[TBL] [Abstract][Full Text] [Related]
10. The regulation and signalling of anti-Müllerian hormone in human granulosa cells: relevance to polycystic ovary syndrome.
Dilaver N; Pellatt L; Jameson E; Ogunjimi M; Bano G; Homburg R; D Mason H; Rice S
Hum Reprod; 2019 Dec; 34(12):2467-2479. PubMed ID: 31735954
[TBL] [Abstract][Full Text] [Related]
11. Elevated serum levels of anti-Müllerian hormone can be introduced as a new diagnostic marker for polycystic ovary syndrome.
Sahmay S; Atakul N; Aydogan B; Aydin Y; Imamoglu M; Seyisoglu H
Acta Obstet Gynecol Scand; 2013 Dec; 92(12):1369-74. PubMed ID: 23980726
[TBL] [Abstract][Full Text] [Related]
12. Serum anti-Müllerian hormone levels remain high until late reproductive age and decrease during metformin therapy in women with polycystic ovary syndrome.
Piltonen T; Morin-Papunen L; Koivunen R; Perheentupa A; Ruokonen A; Tapanainen JS
Hum Reprod; 2005 Jul; 20(7):1820-6. PubMed ID: 15802325
[TBL] [Abstract][Full Text] [Related]
13. The relationship between serum anti-Müllerian hormone levels and the follicular arrest for women with polycystic ovary syndrome.
Li J; Li R; Yu H; Zhao S; Yu Y; Qiao J
Syst Biol Reprod Med; 2015 Apr; 61(2):103-9. PubMed ID: 25329139
[TBL] [Abstract][Full Text] [Related]
14. The dynamics of serum anti-Mullerian-hormone levels during controlled ovarian hyperstimulation with GnRH-antagonist short protocol in polycystic ovary syndrome and low responders.
Weintraub A; Margalioth EJ; Chetrit AB; Gal M; Goldberg D; Alerhand S; Eldar-Geva T
Eur J Obstet Gynecol Reprod Biol; 2014 May; 176():163-7. PubMed ID: 24630573
[TBL] [Abstract][Full Text] [Related]
15. AMH in combination with SHBG for the diagnosis of polycystic ovary syndrome.
Calzada M; López N; Noguera JA; Mendiola J; Hernández AI; Corbalán S; Sanchez M; Torres AM
J Obstet Gynaecol; 2019 Nov; 39(8):1130-1136. PubMed ID: 31208261
[TBL] [Abstract][Full Text] [Related]
16. Anti-Müllerian Hormone Levels in Adolescence in Relation to Long-term Follow-up for Presence of Polycystic Ovary Syndrome.
Caanen MR; Peters HE; van de Ven PM; Jüttner AMFM; Laven JSE; van Hooff MHA; Lambalk CB
J Clin Endocrinol Metab; 2021 Mar; 106(3):e1084-e1095. PubMed ID: 33351079
[TBL] [Abstract][Full Text] [Related]
17. The circadian variation in Anti-Müllerian hormone in patients with polycystic ovary syndrome differs significantly from normally ovulating women.
Bungum L; Franssohn F; Bungum M; Humaidan P; Giwercman A
PLoS One; 2013; 8(9):e68223. PubMed ID: 24023708
[TBL] [Abstract][Full Text] [Related]
18. Characterization of women with elevated antimüllerian hormone levels (AMH): correlation of AMH with polycystic ovarian syndrome phenotypes and assisted reproductive technology outcomes.
Tal R; Seifer DB; Khanimov M; Malter HE; Grazi RV; Leader B
Am J Obstet Gynecol; 2014 Jul; 211(1):59.e1-8. PubMed ID: 24593938
[TBL] [Abstract][Full Text] [Related]
19. Relative importance of AMH and androgens changes with aging among non-obese women with polycystic ovary syndrome.
Kushnir VA; Halevy N; Barad DH; Albertini DF; Gleicher N
J Ovarian Res; 2015 Jul; 8():45. PubMed ID: 26156856
[TBL] [Abstract][Full Text] [Related]
20. [Value of anti-Müllerian hormone in predicting pregnant outcomes of polycystic ovary syndrome patients undergone assisted reproductive technology].
Li Y; Tan JQ; Mai ZY; Yang DZ
Zhonghua Fu Chan Ke Za Zhi; 2018 Jan; 53(1):23-30. PubMed ID: 29374882
[No Abstract] [Full Text] [Related]
[Next] [New Search]
